PKP2-ARVC
3 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Long-term Follow-up Study of Gene Therapy for Arrhythmogenic Cardiomyopathy Due to a Plakophilin-2 Pathogenic Variant (NCT07050160) | Lexeo Therapeutics | 2025-08-29 |
| Gene Therapy for ACM Due to a PKP2 Pathogenic Variant (NCT06109181) | Lexeo Therapeutics | 2024-02-29 |
| A Study to Assess Real-world Patient Characteristics and Clinical Course for Symptomatic Patients With PKP2-ACM (NCT06976606) | Lexeo Therapeutics | 2024-01-23 |
Track PKP2-ARVC automatically
Every clearance here is in the API, with alerts when new ones post.